Nutex Health (NASDAQ:NUTX) Trading 10.3% Higher – Should You Buy?

Nutex Health Inc. (NASDAQ:NUTXGet Free Report) was up 10.3% on Thursday . The stock traded as high as $130.10 and last traded at $131.8130. Approximately 68,978 shares changed hands during mid-day trading, a decline of 63% from the average daily volume of 188,765 shares. The stock had previously closed at $119.45.

Analyst Ratings Changes

Several equities analysts have weighed in on NUTX shares. Wall Street Zen raised Nutex Health from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Weiss Ratings raised Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Nutex Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $205.00.

Check Out Our Latest Stock Report on NUTX

Nutex Health Price Performance

The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.12 and a current ratio of 3.14. The company has a market cap of $925.29 million, a price-to-earnings ratio of 10.39 and a beta of 0.25. The business has a fifty day moving average price of $110.70 and a 200 day moving average price of $127.52.

Nutex Health (NASDAQ:NUTXGet Free Report) last posted its quarterly earnings results on Thursday, April 30th. The company reported $6.52 EPS for the quarter, topping analysts’ consensus estimates of $3.99 by $2.53. Nutex Health had a return on equity of 23.50% and a net margin of 10.95%.The company had revenue of $216.49 million during the quarter, compared to analysts’ expectations of $227.80 million.

Hedge Funds Weigh In On Nutex Health

A number of institutional investors have recently modified their holdings of NUTX. Deutsche Bank AG grew its position in Nutex Health by 3.9% during the 4th quarter. Deutsche Bank AG now owns 2,633 shares of the company’s stock worth $433,000 after acquiring an additional 98 shares during the last quarter. Russell Investments Group Ltd. grew its position in Nutex Health by 1.4% during the 4th quarter. Russell Investments Group Ltd. now owns 8,706 shares of the company’s stock worth $1,433,000 after acquiring an additional 116 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al grew its position in Nutex Health by 3.7% during the 4th quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 5,600 shares of the company’s stock worth $922,000 after acquiring an additional 200 shares during the last quarter. Islay Capital Management LLC bought a new stake in Nutex Health during the 4th quarter worth $34,000. Finally, First Trust Advisors LP grew its position in Nutex Health by 2.4% during the 4th quarter. First Trust Advisors LP now owns 11,461 shares of the company’s stock worth $1,887,000 after acquiring an additional 272 shares during the last quarter. Institutional investors and hedge funds own 5.32% of the company’s stock.

About Nutex Health

(Get Free Report)

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.

Featured Stories

Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.